Related Experiment Video
Updated: Sep 21, 2025
Optimized PCR-based Detection of Mycoplasma
Published on: June 20, 2011
Development of a duplex recombinase-aided amplification assay for direct detection of Mycoplasma pneumoniae and
Ming-Zhu Nie1, Rui-Qing Zhang2, Meng-Chuan Zhao3
1Hebei Medical University, Shijiazhuang 050031, Hebei, China; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Street, Changping District, Beijing 102206, China.
Background:
Pneumonia caused by Mycoplasma pneumoniae is common in the elderly and children, and pneumonia caused by Chlamydia trachomatis is prevalent in newborns. This study aimed to establish a rapid, sensitive, and simple method for the direct detection of M. pneumoniae and C. trachomatis in clinical samples without DNA extraction.
Methods:
We established a duplex recombinase-aided amplification (RAA) assay with the RNAseP gene as an internal control for detecting the P1 gene of M. pneumoniae and the ORF8 gene of C. trachomatis, respectively. The results were obtained at 39 °C within 15-20 min. A total of 130 clinical samples suspected of M. pneumoniae or C. trachomatis infection were collected and tested by duplex RAA and PCR. DNA extracted via a commercial kit or treated with a nucleic acid-releasing agent was used and compared, respectively. Standard recombinant plasmids were used to test the sensitivity of the duplex RAA assay. In addition, other similar common pathogens were used to verify the specificity of the duplex RAA assay.
Results:
The sensitivity of the duplex RAA assay for detecting M. pneumoniae and C. trachomatis was 10 copies/μL using recombinant plasmids. Compared with PCR, the sensitivity and specificity of duplex RAA assays for M. pneumoniae and C. trachomatis was 100% using clinical DNA samples extracted using a commercial kit and a nucleic acid-releasing agent, and the Kappa value was 1.
Conclusion:
The advantages of this duplex RAA assay include high sensitivity and specificity, short duration, and simple extraction steps, with potential for use in the on-site detection of M. pneumoniae and C. trachomatis in resource-limited settings.
Insights
A new duplex recombinase-aided amplification (RAA) assay rapidly detects Mycoplasma pneumoniae and Chlamydia trachomatis. This sensitive method offers accurate results for these common pneumonia-causing pathogens without DNA extraction.
Area of Science:
- Molecular Biology
- Infectious Diseases
- Diagnostic Assays
Background:
- Mycoplasma pneumoniae and Chlamydia trachomatis are significant causes of pneumonia in various age groups.
- Current detection methods can be time-consuming and require complex sample preparation.
Purpose of the Study:
- To develop a rapid, sensitive, and simple method for direct detection of M. pneumoniae and C. trachomatis.
- To eliminate the need for DNA extraction in clinical samples.
Main Methods:
- A duplex recombinase-aided amplification (RAA) assay was developed targeting specific genes of M. pneumoniae and C. trachomatis.
- An internal control (RNAseP gene) was incorporated for assay validation.
- The assay was optimized for a 39°C incubation, yielding results within 15-20 minutes.
- Clinical samples were tested using duplex RAA and compared against PCR, with and without DNA extraction.
Main Results:
- The duplex RAA assay demonstrated high sensitivity, detecting as low as 10 copies/μL of target DNA.
- Compared to PCR, the RAA assay achieved 100% sensitivity and specificity for both pathogens.
- The assay showed excellent agreement with PCR (Kappa value of 1) even with simplified nucleic acid release methods.
Conclusions:
- The developed duplex RAA assay is a highly sensitive and specific method for detecting M. pneumoniae and C. trachomatis.
- Its rapid nature, simplicity, and minimal sample preparation requirements make it suitable for resource-limited settings.
- This assay holds potential for on-site diagnosis of these common respiratory infections.
